赵建国;廖泉;赵玉沛;

• 1:中国医学科学院 北京协和医学院 北京协和医院基本外科

摘要(Abstract)：

<正>约80%～85%的原发性甲状旁腺功能亢进(primary hyperparathyroidism,PHPT)由甲状旁腺良性肿瘤引起,15%～20%的病例由增生引起,<1%的病例由甲状旁腺癌引起[1]。目前,随着医学发展,甲状旁腺肿瘤疾病已越来越多地被认识和发现,但关于本病发生发展分子水平方面的研究报道较少。随着肿瘤分子生物学研究的进展,其机制正在被逐步阐明,本文就甲状旁腺肿瘤的分子生物学研究进展加以综述。

关键词(KeyWords)： 甲状旁腺肿瘤;分子生物学

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 赵建国;廖泉;赵玉沛;

Email:

DOI:

参考文献(References)：

• [1]Marx SJ.Hyperparathyroid and hypoparathyroid disorders[J].N Engl J Med,2000,343:1863-1875.
• [2]Hou R,Manwaring LP,Moley JF,et al.A novel missense mutation in the MEN1gene in a patient with multiple endo-crine neoplasia type1[J].Endocr Pract,2011,17:e63-e67.
• [3]Lemos MC,Thakker RV.Multiple endocrine neoplasia type1(MEN1):analysis of1336mutations reported in the first dec-ade following identification of the gene[J].Hum Mutat,2008,29:22-32.
• [4]Dreijerink KM,Hoppener JW,Timmers HM,et al.Mecha-nisms of disease:multiple endocrine neoplasia type1-relation to chromatin modifications and transcription regulation[J].Nat Clin Pract Endocrinol Metab,2006,2:562-570.
• [5]Davenport C,Agha A.The role of menin in parathyroid tu-morigenesis[J].Adv Exp Med Biol,2009,668:79-86.
• [6]Yu D,Nagamura Y,Shimazu S,et al.Caspase8and menin expressions are not correlated in human parathyroid tumors[J].Endocr J,2010,57:825-832.
• [7]Buchwald PC,Akerstrom G,Westin G.Reduced p18INK4c,p21CIP1/WAF1and p27KIP1mRNA levels in tumours of pri-mary and secondary hyperparathyroidism[J].Clin Endocri-nol(Oxf),2004,60:389-393.
• [8]Nagamura Y,Yamazaki M,Shimazu S,et al.A novel splice site mutation of the MEN1gene identified in a patient with pri-mary hyperparathyroidism[J].Endocr J,2012,59:523-530.
• [9]Busygina V,Kottemann MC,Scott KL,et al.Multiple endo-crine neoplasia type1interacts with forkhead transcription factor CHES1in DNA damage response[J].Cancer Res,2006,66:8397-8403.
• [10]Schnepp RW,Hou Z,Wang H,et al.Functional interaction between tumor suppressor menin and activator of S-phase ki-nase[J].Cancer Res,2004,64:6791-6796.
• [11]Carpten JD,Robbins CM,Villablanca A,et al.HRPT2,en-coding parafibromin,is mutated in hyperparathyroidism-jaw tumor syndrome[J].Nat Genet,2002,32:676-680.
• [12]Rodgers SE,Perrier ND.Parathyroid carcinoma[J].Curr Opin Oncol,2006,18:16-22.
• [13]Lin L,Zhang JH,Panicker LM,et al.The parafibromin tumor suppressor protein inhibits cell proliferation by repres-sion of the c-myc proto-oncogene[J].Proc Natl Acad Sci USA,2008,105:17420-17425.
• [14]Lin L,Czapiga M,Nini L,et al.Nuclear localization of the parafibromin tumor suppressor protein implicated in the hyper-parathyroidism-jaw tumor syndrome enhances its proapoptotic function[J].Mol Cancer Res,2007,5:183-193.
• [15]Rozenblatt-Rosen O,Hughes CM,Nannepaga SJ,et al.The parafibromin tumor suppressor protein is part of a human Paf1complex[J].Mol Cell Biol,2005,25:612-620.
• [16]Westin G,Bjorklund P,Akerstrom G.Molecular genetics of parathyroid disease[J].World J Surg,2009,33:2224-2233.
• [17]Panicker LM,Zhang JH,Dagur PK,et al.Defective nucleo-lar localization and dominant interfering properties of a parafi-bromin l95p missense mutant causing the hyperparathyroid-ism-jaw tumor syndrome[J].Endocr Relat Cancer,2010,17:513-524.
• [18]Lim S,Elston MS,Gill AJ,et al.Metastatic parathyroid car-cinoma initially misdiagnosed as parathyroid adenoma:the role of parafibromin in increasing diagnostic accuracy[J].Intern Med J,2011,41:695-699.
• [19]Juhlin CC,Haglund F,Obara T,et al.Absence of nucleolar parafibromin immunoreactivity in subsets of parathyroid malig-nant tumours[J].Virchows Arch,2011,459:47-53.
• [20]Juhlin CC,Villablanca A,Sandelin K,et al.Parafibromin immunoreactivity:its use as an additional diagnostic marker for parathyroid tumor classification[J].Endocr Relat Canc-er,2007,14:501-512.
• [21]Howell VM,Gill A,Clarkson A,et al.Accuracy of com-bined protein gene product9.5and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma[J].J Clin Endocrinol Metab,2009,94:434-441.
• [22]Farnebo F,Enberg U,Grimelius L,et al.Tumor-specific de-creased expression of calcium sensing receptor messenger ri-bonucleic acid in sporadic primary hyperparathyroidism[J].J Clin Endocrinol Metab,1997,82:3481-3486.
• [23]Mallya SM,Gallagher JJ,Wild YK,et al.Abnormal para-thyroid cell proliferation precedes biochemical abnormalities in a mouse model of primary hyperparathyroidism[J].Mol En-docrinol,2005,19:2603-2609.
• [24]Ward BK,Magno AL,Walsh JP,et al.The role of the calci-um-sensing receptor in human disease[J].Clin Biochem,2012,45:943-953.
• [25]Cozzolino M,Mazzaferro S,Messa P.New insights into the role of calcium-sensing receptor activation[J].J Nephrol,2011,24:S38-S41.
• [26]Falchetti A,Gozzini A,Terranegra A,et al.A novel germ-line inactivating mutation in the CASR gene in an Italian kin-dred affected by familial hypocalciuric hypercalcemia[J].Eur J Endocrinol,2012,166:933-940.
• [27]Canaff L,Zhou X,Mosesova I,et al.Glial cells missing-2(GCM2)transactivates the calcium-sensing receptor gene:effect of a dominant-negative GCM2mutant associated with au-tosomal dominant hypoparathyroidism[J].Hum Mutat,2009,30:85-92.
• [28]Motokura T,Bloom T,Kim HG,et al.A novel cyclin enco-ded by a bcl1-linked candidate oncogene[J].Nature,1991,350:512-515.
• [29]Erickson LA,Jalal SM,Harwood A,et al.Analysis of para-thyroid neoplasms by interphase fluorescence in situ hybridiza-tion[J].Am J Surg Pathol,2004,28:578-584.
• [30]Yi Y,Nowak NJ,Pacchia AL,et al.Chromosome11ge-nomic changes in parathyroid adenoma and hyperplasia:array cgh,fish,and tissue microarrays[J].Genes Chromosomes Cancer,2008,47:639-648.
• [31]Westin G,Bjorklund P,Akerstrom G.Molecular genetics of parathyroid disease[J].World J Surg,2009,33:2224-2233.
• [32]Cetani F,Pardi E,Viacava P,et al.A reappraisal of the Rb1gene abnormalities in the diagnosis of parathyroid cancer[J].Clin Endocrinol(Oxf),2004,60:99-106.
• [33]Imanishi Y,Hosokawa Y,Yoshimoto K,et al.Primary hy-perparathyroidism caused by parathyroid-targeted overexpres-sion of cyclin D1in transgenic mice[J].J Clin Invest,2001,107:1093-1102.
• [34]Erickson LA,Jin L,Wollan PC,et al.Expression of p27KIP1and Ki-67in benign and malignant thyroid tumors[J].Mod Pathol,1998,11:169-174.
• [35]DeLellis RA.Parathyroid carcinoma:an overview[J].Adv Anat Pathol,2005,12:53-61.
• [36]Fernandez-Ranvier GG,Khanafshar E,Tacha D,et al.Defi-ning a molecular phenotype for benign and malignant parathy-roid tumors[J].Cancer,2009,115:334-344.
• [37]Chen CH,Chuang SM,Yang MF,et al.A novel function of YWHAZ/β-catenin axis in promoting epithelial-mesenchymal transition and lung cancer metastasis[J].Mol Cancer Res,2012,10:1319-1331.
• [38]Morrison DK.The14-3-3proteins:integrators of diverse sig-naling cues that impact cell fate and cancer development[J].Trends Cell Biol,2009,19:16-23.
• [39]Bayrhuber M,Meins T,Habeck M,et al.Structure of the human voltage-dependent anion channel[J].Proc Natl Acad Sci U S A,2008,105:15370-15375.
• [40]Giusti L,Cetani F,Ciregia F,et al.A proteomic approach to study parathyroid glands[J].Mol Biosyst,2011,7:687-699.